These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12710078)

  • 1. [The clinicopathological characteristics in renal cell carcinoma with end-stage renal disease].
    Maru N; Iwamura M; Ishii J; Minei S; Saito T; Yoshida K; Baba S
    Nihon Hinyokika Gakkai Zasshi; 2003 Mar; 94(3):434-8. PubMed ID: 12710078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.
    Shrewsberry AB; Osunkoya AO; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master VA; Ogan K
    Clin Transplant; 2014 Feb; 28(2):211-6. PubMed ID: 24494735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
    Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
    World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma.
    Ishihara H; Fukuda H; Tachibana H; Yoshida K; Kobayashi H; Takagi T; Iizuka J; Ishida H; Nagashima Y; Kondo T; Tanabe K
    Clin Exp Nephrol; 2021 Jun; 25(6):674-682. PubMed ID: 33641007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
    Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell and non-clear cell renal cell carcinoma in young adults: clinicopathological features, survival outcomes and prognostic factors.
    Xue Z; Tang S; Ou J; Fang Y; Qiu M; Hong K; Tian X; Zhang H; Liu C; Ma L; Zhang S
    World J Urol; 2024 May; 42(1):364. PubMed ID: 38819448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal Cell Carcinomas in Patients on Chronic Dialysis].
    Matsuda T; Mochizuki Y; Mukae Y; Nakanishi H; Mitsunari K; Matsuo T; Hakariya T; Ohba K; Miyata Y; Nishino T; Sakai H
    Hinyokika Kiyo; 2022 Dec; 68(12):369-376. PubMed ID: 36627770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal cell carcinoma in patients with end-stage renal disease: a clinicopathological analysis].
    He B; Zhang W; Liu LN; Wang H; Zou YW; Jiang YX; Yu WJ; Shi HL; Liu Y; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):846-850. PubMed ID: 31775432
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal disease.
    Ikezawa E; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Takagi T; Omae K; Tanabe K
    Jpn J Clin Oncol; 2014 Nov; 44(11):1096-100. PubMed ID: 25139162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma and end stage renal disease.
    Farivar-Mohseni H; Perlmutter AE; Wilson S; Shingleton WB; Bigler SA; Fowler JE
    J Urol; 2006 Jun; 175(6):2018-20; discussion 2021. PubMed ID: 16697788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.
    Hashimoto Y; Takagi T; Kondo T; Iizuka J; Kobayashi H; Omae K; Yoshida K; Tanabe K
    Int J Clin Oncol; 2015 Oct; 20(5):1035-41. PubMed ID: 25762166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic characterization of renal epithelial neoplasms arising in nonfunctioning kidneys.
    Lin X; Goyal R; Yang XJ
    Hum Pathol; 2020 Mar; 97():1-7. PubMed ID: 31857138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
    Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
    Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.